Nifty On Gradual Dip: Top 5 Stocks To Buy For Long-Term Gains
V.L.A Ambala, a SEBI-registered Research Analyst, shares insights on the current market scenario and recommends top 5 stocks to buy for long-term gains.
V.L.A Ambala, a SEBI-registered Research Analyst, shares insights on the current market scenario and recommends top 5 stocks to buy for long-term gains.
Hindalco Industries is confident of replicating its strong Q1 performance across FY26, driven by high metal prices and operational efficiency. Get the latest updates on the company’s growth strategy and outlook for the Indian stock market.
Fort Capital’s Head of Fund Management, Parag Thakkar, expects the Indian market to be only slightly disappointed by the lack of a deal after the Trump-Putin summit, as domestic positives take center stage.
Motilal Oswal Financial Services Ltd. sees the corporate earnings in the April-June quarter as ‘modest but resilient’, with the severity of earnings cuts moderating compared to the previous quarters. The earnings per share, or EPS growth for Nifty 50 is projected to rise to around 9% in fiscal year 2026.
The week ahead promises to be action-packed for financial markets, with Jerome Powell’s speech, key global economic data, and IPO buzz set to drive market trends. Get the latest updates and analysis.
The benchmark equity indices closed flat on Wednesday, with shares of Wipro, Eternal, and HDFC Life contributing positively to the index. Nifty snapped its six-week losing streak, led by Apollo Hospital, Eternal, and Cipla.
Hindustan Copper’s Q1 profit takes a hit, down 29% to Rs 134 crore. What led to this decline and how will it impact investors? Get the latest updates on the Indian stock market and Q1 earnings.
Inox Wind’s Q1 results are out, with net profit more than doubling to Rs 97.34 crore. What does this mean for investors and the future of renewable energy in India?
Patanjali Foods Ltd. reported a 31% decline in its year-on-year net profit for the first quarter of FY26, despite a 24% increase in revenue. Get the latest updates on the Indian stock markets and Q1 results.
Glenmark Pharmaceuticals’ Q1 results reveal an 86% drop in net profit despite a one-time gain. What does this mean for investors and the future of the company?